DEPARTMENT OF THE ARMY U.S. ARMY RESEARCH, DEVELOPMENT AND ENGINEERING COMMAND ACQUISITION CENTER RESEARCH TRIANGLE PARK DIVISION P.O. BOX 12211 RESEARCH TRIANGLE PARK, NORTH CAROLINA ###-###-####
Exhibit 10.72
REPLY TO | DEPARTMENT OF THE ARMY U.S. ARMY RESEARCH, DEVELOPMENT AND ENGINEERING COMMAND ACQUISITION CENTER RESEARCH TRIANGLE PARK DIVISION | |
|
|
|
|
| [stamp:] April 26, 2010 |
AMSRD-ACC-R 70-1t
Subject: Contract No. W911NF-09-C-0072 (Proposal 56273-CH-CBD2)
Bio Protection Systems Corporation
Attn: Mr. Carl Langren
2901 South Loop Drive
Suite 2236
Ames, IA 50010-8646
Dear Mr. Carl Langren:
Enclosed for your retention is a signed copy of subject contract that has been signed by all the parties.
All correspondence pertaining to the scientific and technical aspects of the contract should be directed to the Government technical monitor specified in the contract. Other correspondence should be directed to the undersigned at ###-###-#### or ***@***.
| Sincerely, |
|
|
|
|
| /s/ Leroy R. Hardy Jr. |
|
|
| Leroy R. Hardy Jr. |
| Contracting Officer |
Enclosures
SECTION SF 30 BLOCK 14 CONTINUATION PAGE
SUMMARY OF CHANGES
The purpose of this modification is to: (1) exercise contract line item number (CLIN) 0002 in accordance with the terms and conditions established in the above noted contract; and (2) fully fund CLIN 0002 in the amount of $119,261.00. Therefore, the following changes are hereby incorporated:
SECTION A SOLICITATION/CONTRACT FORM
1. The total cost of this contract was increased by $119,261.00 from $630,738.00 to $749,999.00.
SECTION B - SUPPLIES OR SERVICES AND PRICES
2. CLIN 0002: The word Option is hereby deleted in its entirety and CLIN 0002 is exercised and fully funded as follows:
ITEM NO 0002 |
| SUPPLIES/SERVICES |
| QUANTITY |
| UNIT |
| UNIT PRICE |
| AMOUNT |
| |
|
| Scientific Research Services Phase II |
|
|
| |||||||
|
| Cost Plus Fixed Fee |
|
|
| |||||||
|
| Small Business Innovative Research (SBIR) Phase II proposal titled, Imp roved Venezuelan Equine Encephalitis Virus Vaccines sets forth the research to be completed under this contract line item number. |
|
|
| |||||||
|
|
|
|
|
| |||||||
|
| Purchase Request Number: 56273CHCBD209265 |
|
|
| |||||||
|
| Project: CBD08-105 |
|
|
| |||||||
|
|
|
|
|
| ESTIMATED COST |
| $ | 112,510.00 |
| ||
|
|
|
|
|
| FIXED FEE |
| $ | 6,751.00 |
| ||
|
|
|
|
|
| TOTAL EST COST + FEE |
| $ | 119,261.00 |
|
ITEM NO |
| SUPPLIES/SERVICES |
| QUANTITY |
| UNIT |
| UNIT PRICE |
| AMOUNT |
| |
|
| Scientific Research Services Phase II |
|
|
|
|
| |||||
|
| Cost Plus Fixed Fee |
|
|
|
|
| |||||
|
| Increment of Funding |
|
|
|
|
| |||||
|
|
|
|
|
|
|
| |||||
|
| Purchase Request Number: 56273CHCBD209265-0001 |
|
|
|
|
| |||||
|
| Project: CBD08-105 |
|
|
|
|
| |||||
Total amount Funded: ACRN AB |
|
|
|
|
|
|
| $ | 372.00 |
| ||
CIN: 56273CHCBD209265000201 |
|
|
|
|
|
|
|
|
| |||
ITEM NO 000202 |
| SUPPLIES/SERVICES |
| QUANTITY |
| UNIT |
| UNIT PRICE |
| AMOUNT |
| |
|
| Scientific Research Services Phase II |
|
|
|
|
| |||||
|
| Cost Plus Fixed Fee |
|
|
|
|
| |||||
|
| Increment of Funding |
|
|
|
|
| |||||
|
|
|
|
|
|
|
| |||||
|
| Purchase Request Number: 56273CHCBD209265-0001 |
|
|
|
|
| |||||
|
| Project: CBD08-105 |
|
|
|
|
|
|
|
|
| |
Total amount Funded: ACRN AC |
|
|
|
|
|
|
| $ | 118,889.00 |
| ||
CIN: 56273CHCBD209265000202 |
|
|
|
|
|
|
|
|
| |||
2
SECTION E - INSPECTION AND ACCEPTANCE
3. The following Acceptance/Inspection Schedule is added for CLIN 0002:
INSPECT AT |
| INSPECT BY |
| ACCEPT AT |
| ACCEPT BY |
Destination |
| Government |
| Destination |
| Government |
SECTION F - DELIVERIES OR PERFORMANCE
4. The Delivery Schedule for CLIN 0002 is shown below:
Period of Performance Ship to Address |
| UIC | ||
31-JUL-2010 |
| Transportation Office - W36QYT |
| W36QYT |
through |
| PR PROP BK ACCT Durham |
|
|
30-JUL-2011 |
| PO Box 12211 |
|
|
|
| Research Triangle Park NC ###-###-#### |
|
|
|
| FOB: Destination |
|
|
SECTION G - CONTRACT ADMINISTRATION DATA
5. The accounting and appropriation data for CLIN 0002 is delineated below:
SubCLIN 000201 |
| 9790400260196N6N7C60605502BPM255YXR00009PM56273CH |
| $ | 372.00 |
|
ACRN AB: |
| SAPM9XSAPM018129 |
|
|
| |
|
| CIN: 56273CHCBD209265000201 |
|
|
| |
|
|
|
|
|
| |
SubCLIN 000202 |
| 9700400260106N6N7C60605502BPM255YXR00000PM56273CHS |
| $ | 118,889.00 |
|
ACRN AC: |
| APM0XSAPM018129 |
|
|
| |
|
| CIN: 56273CHCBD209265000202 |
|
|
|
6. As a result of this modification, the total funded amount for this document is increased by $119.261.00 from $630,738.00 to $749,999.00.
7. The funding obligated under CLIN 0002, ACRN AB and ACRN AC, shall not be disbursed until the start of the performance period denoted in Section F provided herein.
Except as provided herein, all terms and conditions set forth in the above noted contract remains unchanged and in full force and effect.
(End of Summary of Changes)
3